The University of Kentucky Center for Clinical and Translational Science (CCTS) has received a four-year, $19.8 million Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences at the National Institutes of Health.
The mission of the UK CCTS is to accelerate the process of translating discoveries into tangible applications across a wide array of diseases and throughout the lifespan. It provides critical research infrastructure, funding, and services to catalyze innovative, multidisciplinary team science. As the CTSA hub for central Appalachia, the UK CCTS focuses on addressing health disparities in the region and collaborates with universities and hospitals in Kentucky, Ohio, West Virginia, and Tennessee.
There will be a formal announcement of the award at 10:30 a.m. Wednesday at the University of Kentucky College of Pharmacy Atrium, 789 S. Limestone. The announcement will also be livestreamed at https://youtu.be/xxb77MVOQq4.
On hand at the announcement will be Dr. Eli Capilouto, UK President; U.S. Senate Majority Leader Mitch McConnell; U.S. Representative Andy Barr; Dr. Lisa Cassis, UK Vice President for Research; Dr. Robert DiPaola, dean of the UK College of Medicine; Dr. Philip A. Kern, director of the UK Center for Clinical and Translational Science; Brittany Martin, graduate of the Community Leadership Institute of Kentucky; and Dr. Michael Karpf, UK Executive Vice President for Health Affairs
For more information about the UK CCTS, visit www.ccts.uky.edu. For more information about the CTSA grant program visit https://www.ncats.nih.gov/ctsa.
Add Comment